Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Oklahoma › Oklahoma City
Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Oklahoma City, OK
6 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Ap rekriteFaz 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Ap rekriteFaz 2
- OU Health Stephenson Cancer Center, Oklahoma City
- OU Medical Center, Oklahoma City
Circulating Tumor DNA Response In Urothelial Cancer
Ap rekriteFaz 2
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Ap rekriteFaz 1
- Dren Investigational Site, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
Ap rekriteFaz 1
- University of Oklahoma, Oklahoma City
Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil
- Nashville, TN23 etid
- New York City, NY22 etid
- Houston, TX19 etid
- Dallas, TX18 etid
- Edison, NJ18 etid
- Los Angeles, CA17 etid
- Queens, NY15 etid
- Chicago, IL14 etid
- Arlington, VA12 etid
- Boston, MA11 etid
- San Antonio, TX11 etid
- Austin, TX10 etid
Lòt etid nan Oklahoma City
- Kansè Poumon ki pa ti selil28 etid
- Kansè ovè28 etid
- Kansè Endomèt25 etid
- Kansè kolorektal22 etid
- Kansè pwostat21 etid
- Kansè poumon19 etid
- Kansè nan tete17 etid
- Kansè Metastatik16 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè vejik11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.